The after effects of a disease are not only limited to patients. Everyone related to the patients is affected. By improving the patient’s life, we aim to put smiles back on a lot more faces. Our mission is to develop effective patient-friendly solutions for a better tomorrow.
Explore our storyClose to 10 % of the global population suffer from urinary incontinence. That amounts to more than 700 million people experiencing reduced quality of life. Around 50% never receive treatment. With unique medical technology, Nowwell is developing a patient-friendly and effective solution to this widespread problem.
It's our mission to unleash the potential in our teams, and we know that teams perform best when they are diverse, and every team member feels that they belong. It's the unique contributions that drive our success, and we're committed to building a culture where everyone has the opportunity to do meaningful work and be recognized for their efforts. With smiles on our faces and lots of dedication we develop effective patient-friendly solutions for a better tomorrow.
Urinary incontinence is a common problem among the world’s adult population. In the US alone, the Global Forum of Incontinence estimates that on an annual basis it affects approx. 30% of the more than 70.000 patients undergoing removal of their prostate and 30-40% of the 100.000 patients undergoing TURP (Transurethral resection of the prostate) for enlarged prostate. Among women, stress urinary incontinence is also a wide-spread issue, with around 40% of women being affected. Of these, 15% report significant negative impact on daily activities.
Our custom-designed valve technology gives patients suffering from urinary incontinence a patient-friendly, surgery-free and remotely controlled device, allowing them to control employing and closing the urine bladder with an inserted valve in urethra. In other words, we will provide an easy-to-use solution that can help improve the quality of life for millions of people.
Common complications related to urinary incontinence are infections and patients typically need to use diapers and catheters. The goals with our novel valve are to reduce the use of antibiotics needed to treat infections in the urinary tract associated with the use of catheter, to reduce plastic waste by reducing the use of diapers, and increased efficiency among health workers through saved time by not changing diapers and catheters, or treating related infections.
.svg)